Sigma Healthcare Limited
SIG
Rang in aandelen
#1049
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aandeelprijs
$1.95
Marktkapitalisatie
$22.39B
Verandering (1 dag)
-0.18%
Verandering (1 jaar)
-1.35%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Categorie
Healthcare
Winst voor Sigma Healthcare Limited (SIG)
Winst in Jun 2026 TTM: $708.86M
Volgens de meest recente financiële verslagen van Sigma Healthcare Limited bedraagt de huidige winst van het bedrijf $708.86M. In 2024 behaalde het bedrijf een winst van $5.66M, een stijging ten opzichte van de winst van 2023, die $3.85M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Sigma Healthcare Limited van 2001 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $708.86M | 10,096.86% |
| 2025 | $6.95M | 22.78% |
| 2024 | $5.66M | 47.02% |
| 2023 | $3.85M | -165.59% |
| 2022 | $-5.87M | -126.98% |
| 2021 | $21.76M | -306.27% |
| 2020 | $-10.55M | -127.92% |
| 2019 | $37.78M | -40.47% |
| 2018 | $63.46M | 9.21% |
| 2017 | $58.11M | 6.92% |
| 2016 | $54.35M | -7.44% |
| 2015 | $58.71M | -1.86% |
| 2014 | $59.82M | 130.12% |
| 2013 | $26.00M | -65.98% |
| 2012 | $76.42M | -187.31% |
| 2011 | $-87.53M | -67.44% |
| 2010 | $-268.78M | -435.64% |
| 2009 | $80.08M | -18.27% |
| 2008 | $97.98M | -5.93% |
| 2007 | $104.16M | 37.29% |
| 2006 | $75.87M | 249.98% |
| 2004 | $21.68M | 59.62% |
| 2003 | $13.58M | 86.27% |
| 2002 | $7.29M | 86.95% |
| 2001 | $3.90M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $6.46B | 811.04% |
US
|
|
| - | - |
US
|
|
| $2.17B | 206.69% |
US
|
|
| - | - |
US
|
|
| $558.00M | -21.28% |
US
|
